MarketAnalysisMarketAnalysis
NASDAQGS:GH

Guardant Health, Inc. - NASDAQGS:GH - Comprehensive analysis

Free evaluation through quantitative algorithms Guardant Health, Inc. - NASDAQGS:GH

Quant Rating

1

Strong Sell

2

Sell

3

Hold

4

Buy

5

Strong Buy


The overall quant rating is not an average of the factor grades listed.Instead, it gives greater weight to the metrics with the strongest predictive value.

Growth-Scoring Model Detail

Name

Fatcor
Percentage

Total Revenue Growth Over Prior Year

31

Market

98

Sector

83

Gross Profit Growth Over Prior Year

33.3

Market

96

Sector

84

EBITDA Growth Over Prior Year

0

Market

0

Sector

0

EBITA Growth Over Prior Year

0

Market

0

Sector

0

EBIT Growth Over Prior Year

0

Market

0

Sector

0

Earnings from Cont. Ops. Growth Over Prior Year

0

Market

0

Sector

0

Net Income Growth Over Prior Year

0

Market

0

Sector

0

Normalized Net Income Growth Over Prior Year

0

Market

0

Sector

0

Diluted EPS before Extra Growth Over Prior Year

0

Market

0

Sector

0

A/R Growth Over Prior Year

24.2

Market

90

Sector

82

Inventory Growth Over Prior Year

14.75

Market

92

Sector

85

PPE Net Growth Over Prior Year

-7.81

Market

10

Sector

42

Total Assets Growth Over Prior Year

-16.84

Market

3

Sector

25

Tangible Book Value Growth Over Prior Year

0

Market

0

Sector

0

Common Equity Growth Over Prior Year

0

Market

0

Sector

0

Cash from Ops. Growth Over Prior Year

0

Market

0

Sector

0

CAPEX Growth Over Prior Year

72

Market

97

Sector

89

Dividend per Share Growth Over Prior Year

0

Market

36

Sector

48

Levered Free Cash Flow Growth Over Prior Year

0

Market

0

Sector

0

Unlevered Free Cash Flow Growth Over Prior Year

0

Market

0

Sector

0

Profitability-Scoring Model Detail

Name

Fatcor
Percentage

Gross Margin %

61

Market

77

Sector

61

SG&A Margin %

74

Market

100

Sector

71

EBITDA Margin %

-54.29

Market

1

Sector

14

EBITA Margin %

-59.73

Market

1

Sector

15

EBIT Margin %

-60.02

Market

1

Sector

15

Earnings from Cont. Ops Margin %

-59.05

Market

1

Sector

17

Net Income Margin %

-59.05

Market

1

Sector

17

Net Income Avail. for Common Margin %

-59.05

Market

1

Sector

17

Normalized Net Income Margin %

-33.04

Market

1

Sector

19

Levered Free Cash Flow Margin %

-19.87

Market

5

Sector

20

Unlevered Free Cash Flow Margin %

-20

Market

4

Sector

20

Return on Assets %

-16.95

Market

0

Sector

44

Return on Capital %

-20.47

Market

0

Sector

45

Return on Equity %

-4584.47

Market

0

Sector

1

Return on Common Equity %

-4584.47

Market

0

Sector

1

Total Asset Turnover

0.45

Market

43

Sector

59

Sub-Scoring Model

Valuation
Momentum
Growth
Profitability
80
60
40
20
Valuation: 50
Momentum: 97
Growth: 65
Profitability: 15

Valuation-Scoring Model Detail

Name

Fatcor
Percentage

TEV/LTM Total Revenue

8.25

Market

84

Sector

76

TEV/LTM EBITDA

0

Market

0

Sector

0

P/LTM Normalized EPS

0

Market

0

Sector

0

P/BV

0

Market

0

Sector

0

TEV/LTM Unlevered FCF

0

Market

0

Sector

0

Momentum-Scoring Model Detail

Name

Fatcor
Percentage

1M Price Performance

5.29

Market

91

Sector

88

3M Price Performance

18.53

Market

96

Sector

92

6M Price Performance

119

Market

100

Sector

98

9M Price Performance

45.2

Market

97

Sector

92

1Y Price Performance

137

Market

100

Sector

98

Start analyzing Guardant Health, Inc. - NASDAQGS:GH with easy-to-understand research reports

Start analyzing Recent popular companies with easy-to-understand research reports